No recent analyst price targets found for RHHBF.
Latest News for RHHBF
Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal
Eli Lilly (LLY) has agreed to pay $350 million upfront to partner with Innovent Biologics on the joint development of new therapies targeting cancer and immune
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for RHHBF.
Senate Trading
No Senate trades found for RHHBF.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.